author-photo

Emily Piccione

Genentech

5

Papers

20

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Development of a Predictive Model for Cytokine Release Syndrome to Inform Risk Stratification and CRS Management Following Immunotherapy

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Glofitamab step-up dosing (SUD): Complete response rates in updated efficacy data in heavily pretreated relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) patients (pts).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma

2020 Blood
Show All
- Source
- Cite
- Save
Citations (20)